Publications by authors named "Konstantin Zhernosekov"

Claim this Profile
S
Safety and efficacy of [Lu]Lu-SibuDAB in patients with progressive metastatic castration-resistant prostate cancer.
René Fernández, Cristian Soza-Ried, Vasko Kramer, Korbinian Krieger, Cristina Müller, Konstantin Zhernosekov

Eur J Nucl Med Mol Imaging· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biodistribution and dosimetry of [Lu]Lu-SibuDAB in patients with metastatic castration-resistant prostate cancer.
Philipp Ritt, René Fernández, Cristian Soza-Ried, Heinz Nicolai, Horacio Amaral, Konstantin Zhernosekov

Eur J Nucl Med Mol Imaging· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced Renal Uptake of Various Radiopharmaceuticals with Sodium Paraaminohippurate Coadministration in a Rat Model.
Marian Meckel, Stefanie Ehrenberg, Theresa Schmidt, Philipp Ritt, Margret I Moré, Konstantin Zhernosekov

J Nucl Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next?
Philip E Harris, Konstantin Zhernosekov

Front Endocrinol (Lausanne)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Safety and Dosimetry of Lu-DOTA-ZOL for Therapy of Bone Metastases.
René Fernández, Elisabeth Eppard, Wencke Lehnert, Luis David Jiménez-Franco, Cristian Soza-Ried, Konstantin Zhernosekov

J Nucl Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a new class of PSMA radioligands comprising ibuprofen as an albumin-binding entity.
Luisa M Deberle, Martina Benešová, Christoph A Umbricht, Francesca Borgna, Manuel Büchler, Konstantin Zhernosekov

Theranostics· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biodistribution and dosimetry of a single dose of albumin-binding ligand [Lu]Lu-PSMA-ALB-56 in patients with mCRPC.
Vasko Kramer, René Fernández, Wencke Lehnert, Luis David Jiménez-Franco, Cristian Soza-Ried, Konstantin Zhernosekov

Eur J Nucl Med Mol Imaging· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiosynthesis of clinical doses of ⁶⁸Ga-DOTATATE (GalioMedix™) and validation of organic-matrix-based ⁶⁸Ge/⁶⁸Ga generators.
Izabela Tworowska, David Ranganathan, Sanjay Thamake, Ebrahim Delpassand, Alireza Mojtahedi, Konstantin Zhernosekov

Nucl Med Biol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a [177Lu]BPAMD labeling kit and an automated synthesis module for routine bone targeted endoradiotherapy.
Marian Meckel, Alexander Nauth, Jan Timpe, Konstantin Zhernosekov, Ameya D Puranik

Cancer Biother Radiopharm· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model.
Jürgen Grünberg, Dennis Lindenblatt, Holger Dorrer, Susan Cohrs, Konstantin Zhernosekov

Eur J Nucl Med Mol Imaging· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future prospects for SPECT imaging using the radiolanthanide terbium-155 - production and preclinical evaluation in tumor-bearing mice.
Cristina Müller, Eliane Fischer, Martin Behe, Ulli Köster, Holger Dorrer, Konstantin Zhernosekov

Nucl Med Biol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct in vitro and in vivo comparison of (161)Tb and (177)Lu using a tumour-targeting folate conjugate.
Cristina Müller, Josefine Reber, Stephanie Haller, Holger Dorrer, Peter Bernhardt, Konstantin Zhernosekov

Eur J Nucl Med Mol Imaging· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Folate receptor targeted alpha-therapy using terbium-149.
Cristina Müller, Josefine Reber, Stephanie Haller, Holger Dorrer, Ulli Köster, Konstantin Zhernosekov

Pharmaceuticals (Basel)· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promises of cyclotron-produced 44Sc as a diagnostic match for trivalent β--emitters: in vitro and in vivo study of a 44Sc-DOTA-folate conjugate.
Cristina Müller, Maruta Bunka, Josefine Reber, Cindy Fischer, Konstantin Zhernosekov

J Nucl Med· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DOTA conjugate with an albumin-binding entity enables the first folic acid-targeted 177Lu-radionuclide tumor therapy in mice.
Cristina Müller, Harriet Struthers, Christian Winiger, Konstantin Zhernosekov, Roger Schibli

J Nucl Med· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A unique matched quadruplet of terbium radioisotopes for PET and SPECT and for α- and β- radionuclide therapy: an in vivo proof-of-concept study with a new receptor-targeted folate derivative.
Cristina Müller, Konstantin Zhernosekov, Ulli Köster, Karl Johnston, Holger Dorrer

J Nucl Med· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The low-energy β(-) and electron emitter (161)Tb as an alternative to (177)Lu for targeted radionuclide therapy.
Silvia Lehenberger, Christoph Barkhausen, Susan Cohrs, Eliane Fischer, Jürgen Grünberg, Konstantin Zhernosekov

Nucl Med Biol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Processing of generator-produced 68Ga for medical application.
Konstantin P Zhernosekov, Dimitry V Filosofov, Richard P Baum, Peter Aschoff, Heiner Bihl

J Nucl Med· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis